Malin SK, Kirwan JP, Sia CL, González F. Pancreatic -cell dysfunction in polycystic ovary syndrome: role of hyperglycemiainduced nuclear factor-B activation and systemic inflammation. Am J Physiol Endocrinol Metab 308: E770 -E777, 2015. First published February 24, 2015 doi:10.1152/ajpendo.00510.2014.-In polycystic ovary syndrome (PCOS), oxidative stress is implicated in the development of -cell dysfunction. However, the role of mononuclear cell (MNC)-derived inflammation in this process is unclear. We determined the relationship between -cell function and MNC-derived nuclear factor-B (NF-B) activation and tumor necrosis factor-␣ (TNF-␣) secretion in response to a 2-h 75-g oral glucose tolerance test (OGTT) in normoglycemic women with PCOS (15 lean, 15 obese) and controls (16 lean, 14 obese). First-and second-phase -cell function was calculated as glucose-stimulated insulin secretion (insulin/glucose area under the curve for 0 -30 and 60 -120 min, respectively) ϫ insulin sensitivity (Matsuda Index derived from the OGTT). Glucose-stimulated NF-B activation and TNF-␣ secretion from MNC, and fasting plasma thiobarbituric acid-reactive substances (TBARS) and high-sensitivity C-reactive protein (hs-CRP) were also assessed. In obese women with PCOS, first-and second-phase -cell function was lower compared with lean and obese controls. Compared with lean controls, women with PCOS had greater change from baseline in NF-B activation and TNF-␣ secretion, and higher plasma TBARS. -Cell function was inversely related to NF-B activation (1st and 2nd) and TNF-␣ secretion (1st), and plasma TBARS and hs-CRP (1st and 2nd). First-and second-phase -cell function also remained independently linked to NF-B activation after adjustment for body fat percentage and TBARS. In conclusion, -cell dysfunction in PCOS is linked to hyperglycemia-induced NF-B activation from MNC and systemic inflammation. These data suggest that in PCOS, inflammation may play a role in impairing insulin secretion before the development of overt hyperglycemia. insulin secretion; glucose intolerance; androgens; insulin resistance; mononuclear cells; obesity; insulin sensitivity UP TO 70% OF WOMEN WITH POLYCYSTIC ovary syndrome (PCOS) exhibit insulin resistance and are at risk for type 2 diabetes (T2D; see Refs. 7, 10, and 40). The conventional glucoseregulatory response to insulin resistance is a reciprocal rise in pancreatic -cell insulin secretion that maintains normal blood glucose concentrations (29). While this compensatory hyperinsulinemia in PCOS has been reported and linked to elevated androgens (3, 38), defects in -cell function are observed independent of body weight and the degree of insulin resistance (5,6,14,27,40). Consequently, it is not surprising that nearly 50% of women with PCOS develop prediabetes or T2D before the age of 40 (7, 10, 40). Further work is required to elucidate the mechanism involved in this attenuated -cell function to better understand how interventions may prevent hyperglycemia in women with PCOS.Hyperglycemia-indu...